Notably, adoptive transfer of neoepitope-specific CD4+ T cells induced tumor regression in a cholangiocarcinoma patient, providing direct clinical evidence of the anticancer effectiveness of neoantigen-specific T cells (231). This evidence concerns the gene CD4 and neoplasm.